This early-phase trial tests whether a new drug called NCS-01 is safe for people who have had a stroke. Sixteen patients will receive the drug within 48 hours of their stroke. The main goal is to check for side effects, not to see if the drug works. This is a first step to see if…
Phase: PHASE1, PHASE2 • Sponsor: NC Medial Research Inc • Aim: Disease control
Last updated Jun 26, 2026 16:25 UTC